Efficacy and safety of dexamethasone ointment on recurrent aphthous ulceration
- PMID: 22340928
- DOI: 10.1016/j.amjmed.2011.09.011
Efficacy and safety of dexamethasone ointment on recurrent aphthous ulceration
Abstract
Objective: Recurrent aphthous ulceration is the most common oral mucosal lesion and may be associated with many systemic diseases. Topical corticosteroids are used frequently for recurrent aphthous ulceration; however, the number of high-quality clinical experiments available is insufficient, and no reports exist on the blood level of corticosteroids after topical usage in the oral mucosa. The objective was to determine the efficacy and safety of dexamethasone ointment in the treatment of recurrent aphthous ulceration and detect serum dexamethasone concentrations in the patients.
Methods: A randomized, double-blinded, placebo-controlled, parallel, multicenter clinical trial was conducted in 5 centers to compare the efficacy and safety of dexamethasone ointment with placebo. There were 810 patients with minor recurrent aphthous ulcerations screened for study eligibility, and 240 patients were enrolled at 5 centers from March 1, 2009 to April 30, 2010; 120 were assigned randomly to the treatment group and 120 to a control group. Patients were instructed to apply the given agent to the identified ulcer 3 times a day (after meals) for 5 days. The size, pain level, healing ratio, and average duration of ulcers and the safety of the agents were evaluated. The serum concentration of dexamethasone was detected using a high-performance liquid chromatography/mass spectrometry assay.
Results: The results showed that baseline characteristics were similar (P>.5). At day 6 ± 2 after treatment, there was significant difference in the variation of ulcer size between the treatment group (7.167 ± 6.3415 mm(2)) and the control group (4.346 ± 7.0666 mm(2); P = .000); and in the variation of pain level between the treatment group (5.623 ± 1.9570) and the control group (4.940 ± 2.2449; P = .001). The healing ratio was 83.33% in the treatment group and 54.70% in the control group (P = .000). No severe adverse reactions were observed. No serum dexamethasone was detected before or after the use of the agents (<0.502 ng/mL).
Conclusion: Dexamethasone ointment was efficient in the treatment of recurrent aphthous ulceration and was safe as evaluated using clinical assessment and serum level detection.
Copyright © 2012 Elsevier Inc. All rights reserved.
Comment in
-
Topical dexamethasone for recurrent aphthous ulceration reduces pain and size and increases healing with no significant adverse events.Evid Based Med. 2012 Dec;17(6):e15. doi: 10.1136/ebmed-2011-100709. Epub 2012 May 14. Evid Based Med. 2012. PMID: 22584371 No abstract available.
-
Promising results for dexamethasome ointment for treatment of recurrent aphthae.Evid Based Dent. 2012;13(3):75. doi: 10.1038/sj.ebd.6400872. Evid Based Dent. 2012. PMID: 23059918
Similar articles
-
Promising results for dexamethasome ointment for treatment of recurrent aphthae.Evid Based Dent. 2012;13(3):75. doi: 10.1038/sj.ebd.6400872. Evid Based Dent. 2012. PMID: 23059918
-
Evaluation of penicillin G potassium troches in the treatment of minor recurrent aphthous ulceration in a Chinese cohort: a randomized, double-blinded, placebo and no-treatment-controlled, multicenter clinical trial.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Apr;109(4):561-6. doi: 10.1016/j.tripleo.2009.11.006. Epub 2010 Feb 26. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010. PMID: 20188604 Clinical Trial.
-
Silver nitrate cautery in aphthous stomatitis: a randomized controlled trial.Br J Dermatol. 2005 Sep;153(3):521-5. doi: 10.1111/j.1365-2133.2005.06490.x. Br J Dermatol. 2005. PMID: 16120136 Clinical Trial.
-
Major recurrent aphthous ulceration: case report and review of the literature.Conn Med. 2008 May;72(5):271-3. Conn Med. 2008. PMID: 18593062 Review.
-
Management of recurrent aphthous stomatitis. A review.Cutis. 1978 Aug;22(2):183-9. Cutis. 1978. PMID: 357093 Review.
Cited by
-
Combined treatment of dexamethasone mouthwash and low-level laser therapy in the management of aphthous-like ulcers caused by nonsteroidal anti-inflammatory drugs: A case report.Clin Case Rep. 2024 Mar 27;12(4):e8723. doi: 10.1002/ccr3.8723. eCollection 2024 Apr. Clin Case Rep. 2024. PMID: 38550731 Free PMC article.
-
Synthesis and functionalization of mucoadhesive mesoporous silica particles containing diphenhydramine for treatment of aphthous ulcers.Bioimpacts. 2023;13(6):456-466. doi: 10.34172/bi.2023.27548. Epub 2023 Jul 16. Bioimpacts. 2023. PMID: 38022378 Free PMC article.
-
Multifunctional polysaccharide composited microneedle for oral ulcers healing.Mater Today Bio. 2023 Aug 29;22:100782. doi: 10.1016/j.mtbio.2023.100782. eCollection 2023 Oct. Mater Today Bio. 2023. PMID: 37706204 Free PMC article.
-
A Comparative Study of Dexamethasone Ointment along with Triamcinolone Acetonide in Treatment of Recurrent Aphthous Stomatitis.J Pharm Bioallied Sci. 2023 Jul;15(Suppl 2):S1325-S1328. doi: 10.4103/jpbs.jpbs_102_23. Epub 2023 Apr 28. J Pharm Bioallied Sci. 2023. PMID: 37693963 Free PMC article.
-
Management of Recurrent Aphthous Stomatitis: An Indian Expert Consensus.Indian J Otolaryngol Head Neck Surg. 2023 Sep;75(3):2672-2680. doi: 10.1007/s12070-023-03708-2. Epub 2023 Mar 28. Indian J Otolaryngol Head Neck Surg. 2023. PMID: 37636607 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous